# Catridecacog (Genetical Recombination) for I.V. Injection 2500 (ノボサーティーン静注用２５００)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6343443D1027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6343443D1027
- **Product name (Japanese):** ノボサーティーン静注用２５００
- **English title:** Catridecacog (Genetical Recombination) for I.V. Injection 2500
- **Active ingredient:** カトリデカコグ（遺伝子組換え）
- **Active ingredient (INN):** Catridecacog (Genetical Recombination)
- **Strength / unit:** ２，５００国際単位１瓶（溶解液付）
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 634 Blood products (血液製剤類)
- **Manufacturer:** Novo Nordisk Pharma (ノボ ノルディスク ファーマ)
- **NHI price (reference only):** JPY 3716010 per ２，５００国際単位１瓶（溶解液付）
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6343443D1027
- **JSON:** https://www.nifujipharma.com/api/drugs/6343443D1027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Catridecacog%20(Genetical%20Recombination)%20for%20I.V.%20Injection%202500%20(%E3%83%8E%E3%83%9C%E3%82%B5%E3%83%BC%E3%83%86%E3%82%A3%E3%83%BC%E3%83%B3%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%92%EF%BC%95%EF%BC%90%EF%BC%90)%20%2F%20YJ%206343443D1027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.